Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker RXST
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Ronald M. Kurtz MD Chief Medical Officer | RXST RxSight, Inc. | Sale | 5,100 | $6.96 | $35.5K Sale | Form 4 ↗ |
| Sep 2, 2026 | Mark Wilterding Chief Financial Officer | RXST RxSight, Inc. | Sale | 7,765 | $6.96 | $54.0K Sale | Form 4 ↗ |
| Sep 2, 2026 | Ilya Goldshleger Chief Operating Officer | RXST RxSight, Inc. | Sale | 2,041 | $6.96 | $14.2K Sale | Form 4 ↗ |
| Sep 2, 2026 | Eric Weinberg See remarks | RXST RxSight, Inc. | Sale | 2,041 | $6.96 | $14.2K Sale | Form 4 ↗ |
| Mar 12, 2025 | Tamara Fountain Director | RXST RxSight, Inc. | Sale | 7,000 | $25.71 | $180.0K Sale | Form 4 ↗ |
| Jan 22, 2025 | Shweta Maniar Director | RXST RxSight, Inc. | Sale | 3,519 | $30.87 | $108.6K Sale | Form 4 ↗ |
| Jan 16, 2025 | Jesse Anderson Corley Director | RXST RxSight, Inc. | Buy | 1,767 | $31.13 | $55.0K Buy | Form 4 ↗ |
| Jan 15, 2025 | Jesse Anderson Corley Director | RXST RxSight, Inc. | Buy | 1,443 | $31.19 | $45.0K Buy | Form 4 ↗ |
| Nov 29, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,105 | $46.08 | $143.1K Sale | Form 4 ↗ |
| Nov 26, 2024 | Shweta Maniar Director | RXST RxSight, Inc. | Sale | 3,782 | $45.88 | $173.5K Sale | Form 4 ↗ |
| Nov 26, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $45.88 | $142.2K Sale | Form 4 ↗ |
| Nov 22, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $45.00 | $139.5K Sale | Form 4 ↗ |
| Nov 18, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 33 | $45.07 | $1,487 Sale | Form 4 ↗ |
| Nov 18, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,067 | $45.00 | $138.0K Sale | Form 4 ↗ |
| Nov 15, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 4,875 | $46.00 | $224.3K Sale | Form 4 ↗ |
| Nov 13, 2024 | Jesse Anderson Corley Director | RXST RxSight, Inc. | Buy | 1,705 | $44.50 | $75.9K Buy | Form 4 ↗ |
| Nov 13, 2024 | Jesse Anderson Corley Director | RXST RxSight, Inc. | Buy | 4,090 | $44.98 | $184.0K Buy | Form 4 ↗ |
| Nov 13, 2024 | Jesse Anderson Corley Director | RXST RxSight, Inc. | Buy | 5,570 | $45.00 | $250.7K Buy | Form 4 ↗ |
| Nov 12, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 1,330 | $46.13 | $61.4K Sale | Form 4 ↗ |
| Nov 12, 2024 | Jesse Anderson Corley Director | RXST RxSight, Inc. | Buy | 11,111 | $45.37 | $504.1K Buy | Form 4 ↗ |
| Nov 7, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 200 | $55.53 | $11.1K Sale | Form 4 ↗ |
| Nov 7, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 2,900 | $54.96 | $159.4K Sale | Form 4 ↗ |
| Nov 4, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 260 | $51.74 | $13.5K Sale | Form 4 ↗ |
| Nov 4, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 2,840 | $50.98 | $144.8K Sale | Form 4 ↗ |
| Oct 30, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,105 | $51.91 | $161.2K Sale | Form 4 ↗ |
| Oct 28, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $50.64 | $157.0K Sale | Form 4 ↗ |
| Oct 25, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $49.79 | $154.3K Sale | Form 4 ↗ |
| Oct 22, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $49.68 | $154.0K Sale | Form 4 ↗ |
| Oct 18, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 34 | $50.59 | $1,720 Sale | Form 4 ↗ |
| Oct 18, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 69 | $50.57 | $3,489 Sale | Form 4 ↗ |
| Oct 18, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,002 | $50.07 | $150.3K Sale | Form 4 ↗ |
| Oct 16, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $49.78 | $154.3K Sale | Form 4 ↗ |
| Oct 14, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $50.09 | $155.3K Sale | Form 4 ↗ |
| Oct 11, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $50.19 | $155.6K Sale | Form 4 ↗ |
| Oct 10, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,105 | $48.82 | $151.6K Sale | Form 4 ↗ |
| Oct 8, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 3,100 | $48.26 | $149.6K Sale | Form 4 ↗ |
| Oct 4, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 206 | $48.65 | $10.0K Sale | Form 4 ↗ |
| Oct 4, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 28 | $48.47 | $1,357 Sale | Form 4 ↗ |
| Oct 4, 2024 | Ilya Goldshleger See remarks | RXST RxSight, Inc. | Sale | 2,866 | $47.96 | $137.5K Sale | Form 4 ↗ |
| Oct 1, 2024 | Shelley B. Thunen See remarks | RXST RxSight, Inc. | Sale | 278 | $49.45 | $13.7K Sale | Form 4 ↗ |
| Oct 1, 2024 | Shelley B. Thunen See remarks | RXST RxSight, Inc. | Sale | 9,521 | $48.69 | $463.6K Sale | Form 4 ↗ |
| Oct 1, 2024 | Shelley B. Thunen See remarks | RXST RxSight, Inc. | Sale | 5,201 | $47.96 | $249.4K Sale | Form 4 ↗ |
42 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:35 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances